ProPublica Wins Pulitzer for Women Who Died Waiting for Abortion
What: ProPublica honored for its “Life of the Mother” series on women who died due to abortion bans.
Key Line: “The investigations illuminated the profound human cost of these policies.”
DOJ says states can’t overrule FDA—even as future restrictions loom.
A state judge loosens the law—but only slightly—on when abortions can be provided.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
A study finds women with incontinence are more likely to have heart disease risk factors.
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Pulitzer-winning series exposes the deadly impact of abortion bans.
NIH, NSF, and women’s health research all targeted in proposed budget.
New Yorker review highlights how fetal rights are becoming the next legal front.
Jess Valenti flags a suspiciously timed study used to attack abortion pill access.
Legislators push for regulation and oversight of anti-abortion pregnancy centers.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
Over a dozen states are considering bills to expand menopause care and insurance coverage.
Vox explores new science to delay menopause—and whether we should.
A small increase in births among women in their 30s and 40s offsets younger declines.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Maternie analysis shows $31M cut from women’s health research, especially maternal health.
New data reveals most U.S. teen girls live under abortion restrictions.